A recent study by Grange et al. (72) reported that HLA-G-bearing EVs derived from renal cancer cells could impair monocyte-derived DC differentiation and T cell immune responses, indicating the potential of HLA-G-bearing EVs to modulate functions of both the innate and adaptive immune systems. Here, HLA-G is linked to renal carcinoma.